Gilead Sciences: Goodbye Buybacks, Hello M&A?

Citigroup's Robyn Karnauskas and Mohit Bansal wonder if Gilead Sciences' ( GILD ) decision to limit its stock buybacks in the months ahead is a sign that it's ready to engage in M&A:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.